MARAVAI LIFESCIENCES HOLDINGS INC
For the period ended Dec 31, 2023. Filed Feb 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 29, 2024
MRVI$7.86-2.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive (Loss) Income
| Year Ended December 31, | |||
|---|---|---|---|
| 2023 | 2022 | 2021 | |
| Net (loss) income | $(138,375) | $490,663 | $469,250 |
| Other comprehensive income: | |||
| Foreign currency translation adjustments | — | — | 55 |
| Total other comprehensive (loss) income | (138,375) | 490,663 | 469,305 |
| Comprehensive (loss) income attributable to non-controlling interests | (19,346) | 270,458 | 287,224 |
| Total comprehensive (loss) income attributable to Maravai LifeSciences Holdings, Inc. | $(119,029) | $220,205 | $182,081 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.